These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 963022)

  • 1. Synthesis of two biologically active insulin analogues with modifications at the N-terminal and N- and C-terminal amino acid residues.
    Cosmatos A; Okada Y; Katsoyannis PG
    Biochemistry; 1976 Sep; 15(18):4076-82. PubMed ID: 963022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of human [9-leucine-B] Insulin.
    Schwartz G; Katsoyannis PG
    Biochemistry; 1976 Sep; 15(18):4071-76. PubMed ID: 963021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [21-arginine-A] insulin: a biologically active analog.
    Ferderigos N; Cosmatos A; Ferderigos A; Katsoyannis PG
    Int J Pept Protein Res; 1979 Jan; 13(1):43-53. PubMed ID: 422323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Possible involvement of the A20-A21 peptide bond in the expression of the biological activity of insulin. 2. [21-Asparagine diethylamide-A]insulin.
    Chu YC; Burke GT; Chanley JD; Katsoyannis PG
    Biochemistry; 1987 Nov; 26(22):6972-5. PubMed ID: 3322394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elongation of the interchain disulfide bridges of insulin. A synthetic analog.
    Cosmatos A; Katsoyannis PG
    J Biol Chem; 1975 Jul; 250(14):5315-21. PubMed ID: 1141233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of des(tetrapeptide B(1-4)) and des(pentapeptide B(1-5)) human insulins. Two biologically active analogues.
    Schwartz G; Katsoyannis PG
    Biochemistry; 1978 Oct; 17(21):4550-6. PubMed ID: 718857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemical synthesis of [des(tetrapeptide B27--30), Tyr(NH2)26-B] and [des(pentapeptide B26--30), Phe(NH2)25-B] bovine insulins.
    Cosmatos A; Ferderigos N; Katsoyannis PG
    Int J Pept Protein Res; 1979; 14(5):457-71. PubMed ID: 395118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble, prolonged-acting insulin derivatives. III. Degree of protraction, crystallizability and chemical stability of insulins substituted in positions A21, B13, B23, B27 and B30.
    Markussen J; Diers I; Hougaard P; Langkjaer L; Norris K; Snel L; Sørensen AR; Sørensen E; Voigt HO
    Protein Eng; 1988 Jul; 2(2):157-66. PubMed ID: 3072564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Insulin analogues with permuted A chain N-terminus (author's transl)].
    Krail G; Brandenburg D; Zahn H
    Hoppe Seylers Z Physiol Chem; 1975 Jun; 356(6):981-96. PubMed ID: 1181282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Possible involvement of the A20-A21 peptide bond in the expression of the biological activity of insulin. 1. [21-Desasparagine,20-cysteinamide-A]insulin and [21-desasparagine,20-cysteine isopropylamide-A]insulin.
    Chu YC; Wang RY; Burke GT; Chanley JD; Katsoyannis PG
    Biochemistry; 1987 Nov; 26(22):6966-71. PubMed ID: 3322393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A21-Asparaginimide] insulin. Saponification of insulin hexamethyl ester, I.
    Gattner HG; Schmitt EW
    Hoppe Seylers Z Physiol Chem; 1977 Jan; 358(1):105-13. PubMed ID: 838463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. (A14-phenylalanine)insulin: a new synthetic analogue.
    Danho W; Sasaki A; Büllesbach E; Gattner HG; Wollmer A
    Hoppe Seylers Z Physiol Chem; 1980 May; 361(5):747-54. PubMed ID: 7000657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Possible involvement of the A20-A21 peptide bond in the expression of the biological activity of insulin. 3. [21-Desasparagine,20-cysteine ethylamide-A]insulin and [21-desasparagine,20-cysteine 2,2,2-trifluoroethylamide-A]insulin.
    Chu YC; Wang RY; Burke GT; Chanley JD; Katsoyannis PG
    Biochemistry; 1987 Nov; 26(22):6975-9. PubMed ID: 3322395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. (A1-phenylalanine) insulin: a new synthetic analogue.
    Danho W; Sasaki A; Büllesbach E; Föhles J; Gattner HG
    Hoppe Seylers Z Physiol Chem; 1980 May; 361(5):735-46. PubMed ID: 7000656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin analogues with modifications in the beta-turn of the B-chain.
    Wang SH; Hu SQ; Burke GT; Katsoyannis PG
    J Protein Chem; 1991 Jun; 10(3):313-24. PubMed ID: 1910463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contribution of the B16 and B26 tyrosine residues to the biological activity of insulin.
    Hu SQ; Burke GT; Katsoyannis PG
    J Protein Chem; 1993 Dec; 12(6):741-7. PubMed ID: 8136024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [B22-D-arginine]insulin: synthesis and biological properties.
    Knorr R; Danho W; Büllesbach EE; Gattner HG; Zahn H; King GL; Kahn CR
    Hoppe Seylers Z Physiol Chem; 1982 Dec; 363(12):1449-60. PubMed ID: 6761262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and biological activity of seventeen analogues of human insulin.
    Märki F; de Gasparo M; Eisler K; Kamber B; Riniker B; Rittel W; Sieber P
    Hoppe Seylers Z Physiol Chem; 1979 Nov; 360(11):1619-32. PubMed ID: 511097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [12-asparagine-B] human insulin. An analogue with modification in the hydrophobic core of insulin.
    Schwartz GP; Burke GT; Katsoyannis PG
    Int J Pept Protein Res; 1981 Feb; 17(2):243-55. PubMed ID: 7014485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Partial synthesis and properties of des-A1-glycine-insulin (author's transl)].
    Brandenburg D; Biela M; Herbertz L; Zahn H
    Hoppe Seylers Z Physiol Chem; 1975 Jun; 356(6):961-79. PubMed ID: 1237459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.